| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | — |
| R&D Expense | $30.0M | -1.9% |
| SG&A Expense | $11.2M | +34.6% |
| Operating Income | -$31.4M | +19.7% |
| Pre-tax Income | -$30.9M | +20.0% |
| Income Tax | $0 | — |
| Net Income | -$30.9M | +20.0% |
| EPS (Basic) | -$0.37 | +41.3% |
| EPS (Diluted) | -$0.37 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.7M | -32.9% |
| Current Assets | $43.0M | -22.2% |
| Total Assets | $43.8M | -21.5% |
| Current Liabilities | $31.6M | +97.0% |
| Total Liabilities | $32.7M | +91.8% |
| Stockholders' Equity | $11.1M | -71.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | +37.1% |
| Capital Expenditures | $63K | +334.2% |
| Investing Cash Flow | -$63K | -334.2% |
| Financing Cash Flow | $1.3M | -98.2% |
| Free Cash Flow | -$18.2M | +36.9% |
| +41.3% |